Rock Springs Capital Management LP 13D and 13G filings for Tempest Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 2:12 pm Sale | 2023-12-31 | 13G | Tempest Therapeutics, Inc. TPST | Rock Springs Capital Management LP | 0 0.000% | -823,654 (Position Closed) | Filing |
| 2023-02-14 2:57 pm Unchanged | 2022-12-31 | 13G | Tempest Therapeutics, Inc. TPST | Rock Springs Capital Management LP | 823,654 7.830% | 0 (Unchanged) | Filing |
| 2022-01-03 4:15 pm Purchase | 2021-12-22 | 13G | Tempest Therapeutics, Inc. TPST | Rock Springs Capital Management LP | 823,654 11.480% | 513,493 (+165.56%) | Filing |
| 2021-07-15 4:31 pm Sale | 2021-06-28 | 13G | Tempest Therapeutics, Inc. TPST | Rock Springs Capital Management LP | 310,161 4.670% | -331,994 (-51.70%) | Filing |
| 2021-07-08 4:25 pm Purchase | 2021-06-28 | 13G | Tempest Therapeutics, Inc. TPST | Rock Springs Capital Management LP | 642,155 9.680% | 642,155 (New Position) | Filing |